Vahid Eslami | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). 🏥 As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. 🎓 A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. 📈 He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. 🏥 As a medical educator, he has trained over 100 cardiology residents and fellows. 🧑‍⚕️ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

🎓 Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. 🏅 He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. 🫀 He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. 📘 His training solidified his expertise in advanced cardiovascular care and research

🏅 Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) 🎓. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

🧠🔬 Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • 📄 Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – 📊738 citations | 📅2021

  • 📄 Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – 📊87 citations | 📅2022

  • 📄 Atorvastatin versus placebo in patients with covid-19 in intensive care… – 📊76 citations | 📅2022

  • 📄 Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – 📊61 citations | 📅2013

  • 📄 Association of CT-measured cardiac indices with lung involvement in COVID-19 – 📊48 citations | 📅2021

  • 📄 Are women more susceptible to ischemic heart disease? A literature overview – 📊36 citations | 📅2021

  • 📄 Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – 📊31 citations | 📅2021

  • 📄 Extrinsic compression of left main coronary artery by the pulmonary trunk… – 📊28 citations | 📅2009

  • 📄 Management of STEMI during COVID-19: Iranian “247” National Committee’s position paper – 📊26 citations | 📅2021

  • 📄 Prognostic value of inflammatory biomarkers in COVID-19 patients – 📊15 citations | 📅2021

David Song | Cardiovascular Disease | Excellence in Research

Published on by Global Academic Awards

Dr. DavidSong | Cardiovascular Disease | Excellence in Research

Dr. DavidSong, Icahn School of Medicine at Mount Sinai Elmhurst, United States

Dr. David Song is a dedicated cardiologist with extensive medical training and a passion for education and research. He earned his Doctorate of Osteopathic Medicine from Rowan University and completed his Internal Medicine Residency at Icahn School of Medicine. Dr. Song’s accolades include awards for teaching, research, and professionalism. As an Executive Chief Resident, he demonstrated leadership at ISMMS/Elmhurst. Beyond medicine, Dr. Song is a Black Belt in Korean Kumdo and has a history of community service. His commitment extends to mentoring, tutoring, and various leadership roles. 🩺🏆📚

Publication Profile:

Scopus 

Orcid

Education:

Dr. David Song’s academic journey reflects a profound commitment to medical excellence. Beginning with a Bachelor of Science in Neuroscience from Stony Brook University, where he graduated with honors, Magna Cum Laude, Dr. Song continued to Rowan University for his Doctorate of Osteopathic Medicine. He further honed his skills through an Internal Medicine Residency at Icahn School of Medicine, followed by a Chief Residency. Currently, he is pursuing a Clinical Fellowship in Cardiovascular Disease at New York Presbyterian/Queens. Dr. Song’s educational odyssey embodies a relentless pursuit of knowledge and expertise in cardiovascular health. 🩺

Honors and Awards:

Dr. David Song stands as a beacon of academic excellence, adorned with numerous accolades throughout his educational journey. His achievements include being recognized as Internal Medicine PGY-3 Resident Teacher and Resident of the Year at Icahn School of Medicine. Dr. Song’s dedication to research earned him the First Place Research Poster Award and membership in the prestigious Alpha Omega Alpha Honor Medical Society. Notably, he received the Doximity Most Cited Research and Top Published Research Awards, showcasing his impact in the medical field. Beyond academics, his commitment to community service is exemplified by scholarships, leadership awards, and extensive involvement in medical missions. 🏆👨‍⚕️

Work Experience:

Dr. David Song’s multifaceted career includes serving as the Executive Chief Resident at ISMMS/Elmhurst, showcasing his leadership in medical education. His commitment extends to mentorship through the Central Academic Assistance Program at Central Presbyterian Church, where he imparted knowledge to high school students. Dr. Song’s research expertise shines through his role as a Clinical Research Coordinator at Penn Medicine, where he contributed to therapeutic lipid-lowering drug development. His dedication to education continued as a Peer Tutor at Rowan SOM and Head Instructor at Plainview Summer School. Beyond academia, Dr. Song’s analytical skills were honed as an Analytical Chemist, and he contributed significantly as a Research Assistant at Stony Brook University. 🌐👨‍🏫

Research Focus:

Dr. David Song, a distinguished researcher in cardiovascular medicine, has made significant contributions to the field through a prolific body of work. His research focuses on diverse topics, ranging from the intricacies of mitral regurgitation in heart failure to meta-analyses comparing different percutaneous coronary interventions. Dr. Song collaborates with esteemed colleagues, consistently publishing in reputable journals such as Radiology Case Reports and The American Journal of Cardiology. His dedication to unraveling complex medical scenarios, including the impact of COVID-19 on cardiovascular outcomes, showcases a commitment to advancing medical knowledge. 📊🔬

Publication Top Notes:

Ortner syndrome as a presenting symptom of severe chronic mitral regurgitation in heart failure: A case report

Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis

A case report of multiple abscesses caused by Streptococcus intermedius

RETRACTED: Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: A meta-analysis

Too much of a good thing: Immune reconstitution inflammatory syndrome in a patient with Still’s disease

Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis

A rare case of delayed anaplasma phagocytophilum-induced pancytopenia: A diagnostic conundrum

Meta-Analysis Comparing Gender-Based Cardiovascular Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention

Curing the incurable: A case of refractory vasospastic angina